Circulating myeloid‐derived suppressor cells: An independent prognostic factor in patients with breast cancer-Reference-Cited by-同舟云学术

Circulating myeloid‐derived suppressor cells: An independent prognostic factor in patients with breast cancer

Published:2018-10-26 Issue:4 Volume:234 Page:3515-3525
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Safarzadeh Elham¹²³⁴,Hashemzadeh Shahryar⁵,Duijf Pascal H.G.⁶,Mansoori Behzad¹^ORCID,Khaze Vahid¹,Mohammadi Ali¹,Kazemi Tohid³,Yousefi Mehdi³^ORCID,Asadi Milad¹,Mohammadi Hamed¹³,Babaie Farhad¹³,Baradaran Behzad¹³⁷^ORCID

Affiliation:

1. Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran

2. Student Research Committee, Tabriz University of Medical Sciences Tabriz Iran

3. Department of Immunology, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran

4. Department of Microbiology & Immunology, Faculty of Medicine Ardabil University of Medical Sciences Ardabil Iran

5. General and Vascular Surgery Department Tabriz University of Medical Sciences Tabriz Iran

6. University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute Brisbane Australia

7. Stem Cell And Regenerative Medicine Institute (SCARM), Tabriz University of Medical Sciences Tabriz Iran

Funder

Immunology Research Center of Tabriz University of Medical Sciences

the Student Research Committee, Tabriz University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.26896

Reference49 articles.

1. Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients

2. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

3. Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients

4. Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer

5. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives;International Immunopharmacology;2024-12

2. The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence;Frontiers in Oncology;2024-08-01

3. Exosomal PD-L1 induces MDSCs accumulation through IL-6/STAT3 pathway in gastric cancer;2024-04-26

4. Experimental type 1 diabetes metabolically rejuvenates CD8⁺T cells for improved control of tumor growth through an IGF1-IGF1R axis;2024-04-07

5. Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy;International Journal of Molecular Sciences;2024-02-23